2,215
Views
35
CrossRef citations to date
0
Altmetric
Research Article

Plateau hypoxia attenuates the metabolic activity of intestinal flora to enhance the bioavailability of nifedipine

, , , , &
Pages 1175-1181 | Received 21 Mar 2018, Accepted 23 Apr 2018, Published online: 23 May 2018

References

  • Basnyat B, Murdoch DR. (2003). High-altitude illness. Lancet 361:1967–74.
  • Dethlefsen L, Relman DA. (2011). Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 108 Suppl 1:4554–61.
  • Filgueira GCO, Filgueira OAS, Carvalho DM, et al. (2017). Effect of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women. Br J Clin Pharmacol 83:1571–9.
  • Gandhi S, Fleet JL, Bailey DG, et al. (2013). Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. JAMA 310:2544–53.
  • Grigoriev A, Nikitina A, Yaroshenko I, Sidorova A. (2016). Development of a HPLC-MS/MS method for the simultaneous determination of nifedipine and lidocaine in human plasma. J Pharm Biomed Anal 131:13–9.
  • Haiser HJ, Turnbaugh PJ. (2012). Is it time for a metagenomic basis of therapeutics? Science 336:1253–5.
  • Jia W, Xie G, Jia W. (2018). Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol 15:111–28.
  • Kim D. (2015). Gut microbiota-mediated drug-antibiotic interactions. Drug Metab Dispos 43:1581–9.
  • Kim I, Yoo D, Jung I, et al. (2016). Reduced metabolic activity of gut microbiota by antibiotics can potentiate the antithrombotic effect of aspirin. Biochem Pharmacol 122:72–9.
  • Koppel N, Maini Rekdal V, Balskus EP. (2017). Chemical transformation of xenobiotics by the human gut microbiota. Science 356:1246–57.
  • Leser TD, Lindecrona RH, Jensen TK, et al. (2000). Changes in bacterial community structure in the colon of pigs fed different experimental diets and after infection with Brachyspira hyodysenteriae. Appl Environ Microbiol 66:3290–6.
  • Raemsch KD, Sommer J. (1983). Pharmacokinetics and metabolism of nifedipine. Hypertension 5:II18–24.
  • Ramsch KD, Graefe KH, Scherling D, et al. (1986). Pharmacokinetics and metabolism of calcium-blocking agents nifedipine, nitrendipine, and nimodipine. Am J Nephrol 6 Suppl 1:73–80.
  • Rubini A, Catena V, Del Monte D, Bosco G. (2017). The effects of nifedipine on respiratory mechanics investigated by the end-inflation occlusion method in the rat. J Enzyme Inhib Med Chem 32:1–4.
  • Schloss PD, Westcott SL, Ryabin T, et al. (2009). Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75:7537–41.
  • Sket R, Debevec T, Kublik S, et al. (2018). Intestinal metagenomes and metabolomes in healthy young males: inactivity and hypoxia generated negative physiological symptoms precede microbial dysbiosis. Front Physiol 9:198.
  • Soons PA, Schellens JH, Roosemalen MC, Breimer DD. (1991). Analysis of nifedipine and its pyridine metabolite dehydronifedipine in blood and plasma: review and improved high-performance liquid chromatographic methodology. J Pharm Biomed Anal 9:475–84.
  • Swanson HI. (2015). Drug metabolism by the host and gut microbiota: a partnership or rivalry? Drug Metab Dispos 43:1499–504.
  • Wilson ID, Nicholson JK. (2017). Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Transl Res 179:204–22.
  • Yasam VR, Jakki SL, Natarajan J, et al. (2016). A novel vesicular transdermal delivery of nifedipine - preparation, characterization and in vitro/in-vivo evaluation. Drug Deliv 23:619–30.
  • Yoo HH, Kim IS, Yoo DH, Kim DH. (2016). Effects of orally administered antibiotics on the bioavailability of amlodipine: gut microbiota-mediated drug interaction. J Hypertens 34:156–62.
  • Yu AM, Ingelman-Sundberg M, Cherrington NJ, et al. (2017). Regulation of drug metabolism and toxicity by multiple factors of genetics, epigenetics, lncRNAs, gut microbiota, and diseases: a meeting report of the 21st International Symposium on Microsomes and Drug Oxidations (MDO)). Acta Pharm Sin B 7:241–8.
  • Zafren K, Pun M, Regmi N, et al. (2017). High altitude illness in pilgrims after rapid ascent to 4380 M. Travel Med Infect Dis 16:31–4.